KRAS and gastric cancer: Both groups had similar frequencies of TP53 mutations (38% and 31% in gastric cancers with current and past infection, respectively; p = 0.652), KRAS mutations (2% and 9%; p = 0.295), and PIK3CA mutations (4% and 6%; p = 0.641) (Fig. 3a).